NCT02135133 A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL Status COMPLETED Phase PHASE2
NCT02133625 A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02129686 A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients Status COMPLETED Phase NA
NCT02123966 An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease Status TERMINATED Phase PHASE2
NCT02119897 Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients Status COMPLETED Phase NA
NCT02118987 Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization Status COMPLETED Phase PHASE1
NCT02117336 Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Status SUSPENDED Phase PHASE1
NCT02113878 Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck Status COMPLETED Phase PHASE1
NCT02091245 Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02091232 Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study) Status COMPLETED Phase PHASE1
NCT02086175 A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT02057432 Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO) Status COMPLETED Phase NA
NCT02041429 Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca Status COMPLETED Phase PHASE1/PHASE2
NCT02041325 Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias Status COMPLETED Phase PHASE2
NCT02040857 Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer Status COMPLETED Phase PHASE2
NCT02036476 Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Status TERMINATED Phase PHASE2